BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32152220)

  • 21. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
    Radaeva S; Jaruga B; Hong F; Kim WH; Fan S; Cai H; Strom S; Liu Y; El-Assal O; Gao B
    Gastroenterology; 2002 Apr; 122(4):1020-34. PubMed ID: 11910354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
    Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
    J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
    Such L; Zhao F; Liu D; Thier B; Le-Trilling VTK; Sucker A; Coch C; Pieper N; Howe S; Bhat H; Kalkavan H; Ritter C; Brinkhaus R; Ugurel S; Köster J; Seifert U; Dittmer U; Schuler M; Lang KS; Kufer TA; Hartmann G; Becker JC; Horn S; Ferrone S; Liu D; Van Allen EM; Schadendorf D; Griewank K; Trilling M; Paschen A
    J Clin Invest; 2020 Aug; 130(8):4266-4281. PubMed ID: 32427578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-epsilon mediates TNF-alpha-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells.
    Matsumiya T; Prescott SM; Stafforini DM
    J Immunol; 2007 Oct; 179(7):4542-9. PubMed ID: 17878351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
    Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
    Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
    Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
    Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1.
    Wu X; Shao F; Yang Y; Gu L; Zheng W; Wu X; Gu Y; Shu Y; Sun Y; Xu Q
    Int Immunopharmacol; 2014 Dec; 23(2):434-41. PubMed ID: 25261409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src.
    Pan Y; Li G; Zhong H; Chen M; Chen T; Gao L; Wu H; Guo J
    Sci Rep; 2016 Jun; 6():28914. PubMed ID: 27349479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
    Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
    Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2.
    Xu P; Ye S; Li K; Huang M; Wang Q; Zeng S; Chen X; Gao W; Chen J; Zhang Q; Zhong Z; Lin Y; Rong Z; Xu Y; Hao B; Peng A; Ouyang M; Liu Q
    J Exp Clin Cancer Res; 2019 Dec; 38(1):483. PubMed ID: 31805977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative activity of IL-27 on melanoma.
    Yoshimoto T; Morishima N; Mizoguchi I; Shimizu M; Nagai H; Oniki S; Oka M; Nishigori C; Mizuguchi J
    J Immunol; 2008 May; 180(10):6527-35. PubMed ID: 18453571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT1, STAT3 and p38MAPK are involved in the apoptotic effect induced by a chimeric cyclic interferon-alpha2b peptide.
    Blank VC; Peña C; Roguin LP
    Exp Cell Res; 2010 Feb; 316(4):603-14. PubMed ID: 19945455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma.
    Zhu X; Tao X; Lu W; Ding Y; Tang Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):615-624. PubMed ID: 30627776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
    Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
    Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.
    Guo CJ; Yang LS; Zhang YF; Wu YY; Weng SP; Yu XQ; He JG
    PLoS One; 2012; 7(7):e41092. PubMed ID: 22844427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein.
    Humpoliková-Adámková L; Kovařík J; Dušek L; Lauerová L; Boudný V; Fait V; Fojtová M; Krejčí E; Kovařík A
    Eur J Cancer; 2009 May; 45(7):1315-1323. PubMed ID: 19232485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin.
    Liu YX; Xu BW; Niu XD; Chen YJ; Fu XQ; Wang XQ; Yin CL; Chou JY; Li JK; Wu JY; Bai JX; Wu Y; Li SM; Yu ZL
    Pharmacol Res; 2022 Jan; 175():105983. PubMed ID: 34822972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3.
    Kim HS; Kim DC; Kim HM; Kwon HJ; Kwon SJ; Kang SJ; Kim SC; Choi GE
    Sci Rep; 2015 Aug; 5():13414. PubMed ID: 26299368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.